2007

2006

2005

2004

Portefølje Naturvitenskap og teknologi ikon

The research system

Portefølje Humaniora og samfunnsvitenskap ikon

Ground-breaking research

Portefølje Samisk ikon

Sámi society and culture

Portefølje Demokrati, styring og fornyelse ikon

Democracy and global development

Portefølje Velferd, kultur og samfunn ikon

Welfare, culture and society

Portefølje Helse ikon

Health

Portefølje Klima- og polarforskning ikon

Climate and environment

Portefølje Landbasert mat, miljø og bioressurser ikon

Land-based food, the environment and bioresources

Portefølje Energi, transport og lavutslipp ikon

Energy and transport

Portefølje Muliggjørende teknologier ikon

Enabling technologies

Portefølje Industri og tjenestenæringer ikon

Innovation

LTP Climate, environment and environmentally friendly energy

Climate and loss of natural diversity

Internationalization

Societal security and civil preparedness

Renewal in the public sector

Velferdstjenester

Frontpage Image

Marine icon

Petroleum og mineraler

LTP Hav ikon

Oceans and coastal areas

LTP2 Muliggjørende og industrielle teknologier ikon

Enabling and industrial technologies

Trust and community

Professional environment

High quality and accessibility

LTP Climate

Strengthened competitiveness and innovation capacity

LPT Health

 An innovative business community

LTP3 Helse

Portefolje Petroleum Ikon

Portefølje Hav ikon

Portefølje Utdanning og kompetanse ikon

Portefølje Global utvikling og internasjonale relasjoner ikon

Portefølje Livsvitenskap ikon

LTP2 Styrket konkurransekraft og innovasjonsevne ikon

LTP2 Utvikle fagmiljøer av fremragende kvalitet

LTP2 Samfunnssikkerhet og samhørighet ikon

LTP2 Fornyelse i offentlig sektor ikon

LTP2 Klima, miljø og miljøvennlig energi ikon

Forsidebilde optimalisert

project-bank-technical

Et innovativt næringsliv ikon

Muliggjørende teknologier bakgrunn

Marin bakgrunnsbilde

Marin ikon

Forsidebilde

Statistics

Prosjektbanken presenterer statistikk og informasjon om prosjekter med finansiering fra Forskningsrådet fra 2004. Statistikken er fordelt på blant annet tema, år, geografi og organisasjon. Prosjektbanken gir også detaljert informasjon om de enkelte prosjektene.

...or see the summary and other information about the projects you have selected

Portfolios

En god beskrivelse av denne siden for søkemotoroptimalisering

Forside

How the grants are distributed between organisations, counties, subject areas etc....

Here are some examples of searches you can perform in the Project Databank

All long term plan objectives

About Text Queries

No thematic area or topic related to the project

has received funding in the programme period

No popular science description is available

have received funding in the programme period

The project with project number {{project number}} was not found

Technical description

Woops, something went wrong. Please refresh the page. If the error persists, please contact us.

We could not find what you were looking for

See statistics related to this LTP objective

See projects related to this LTP objective

related to this LTP objective have received grants

has been granted to projects related to this LTP objective

has been granted to projects related to this portfolio

related to this portfolio have received grants

About Prosjektbanken

2018

Energidepartementet

Kunnskapsdepartement

Matematikk og naturvitenskap

Oslo

LTP3 Høy kvalitet og tilgjengelighet

LTP3 Fagmiljøer og talenter

Universiteter

UoH-sektor

Instituttsektor

Næringsliv

Helseforetak

Offentlig sektor

Øvrige

Ukjent Sektor

Utlandet

ukjent

Portefølje Banebrytende forskning

Portefølje Forskningssystemet

Frittstående prosjekter

Koordinerings- og støtteaktivitet

Grunnforskning

BOLD MINDS aspires to enhance the understanding of vulnerability factors underlying the emergence of borderline personality disorder (BPD), with an ultimate aim of increasing the potential for young individuals to receive early, evidence-based help when their mental health is at risk. BOLD MINDS will achieve this by investigating whether disruptions in two aspects of autobiographical memory (AM), narrative identity (NI) and involuntary AM (IAM), are associated with BPD features and problem behaviours in adolescents concurrently and over time. In doing so, BOLD MINDS will strengthen the understanding of mechanisms underlying the emergence of BPD in adolescence and lay a groundwork for developing evidence-based early interventions for BPD. While currently limited, the study of AM in this field is essential for two reasons. Firstly, because the aspects of AM under investigation, NI and IAM, are known to be involved in identity formation and emotion regulation which represent two key psychological processes that are disrupted in adults with BPD and are linked to problem behaviours such as self-harm and suicidality. Secondly, because promising research is emerging on the use of AM targets in the treatment of emotional disorder in adults, and provides a strong model for future treatment development with vulnerable adolescents. In addition, this timely research program aligns with calls from international organizations to prioritize early interventions to promote adolescent mental health. BOLD MINDS will adopt and adapt state-of-the-art ecological momentary assessment and analytical techniques and work at the crossroads of clinical and cognitive psychological perspectives, allowing for a multidimensional approach to understanding BPD vulnerability. Training-through-research and formalized training of the experienced researcher will prepare her for a permanent academic position and the founding of her own research lab specializing in AM and early interventions for BPD.

Borderline Personality Disorder: Memory and Identity in Adolescence

Bilingual Experiences, Cognitive Ageing and underlying Mechanisms

The goal of the Bilingual Experiences, Cognitive Ageing and underlying Mechanisms (BECAME) project is to examine the functional neuroplastic mechanisms underlying mitigatory effects of bilingual experience on age-related cognitive decline. While evidence is available for structural brain changes supporting bilingualism-induced effects on cognitive aging (CA), functional mechanisms underlying such effects are not yet well understood. BECAME aims to fill this gap by investigating the trajectory of bilingualism-induced functional neuroplasticity across the adult lifespan (ages 18-85), crucially adopting an individual differences approach related to measurable degree of bilingual engagement. Importantly, although such benefits are thought to be rooted early in the lifespan, evidence for the timeframe and conditions of their early emergence is scarce. The choice of including the whole adult lifespan allows us to investigate these mechanisms and their emergence more directly from a lifespan perspective. I combine behavioral testing with brain recordings via electroencephalography (EEG). EEG is widely used in cognitive neuroscience to assess brain activity and the degree of communication between brain regions (functional connectivity) in response to stimuli and at rest. Combining behavioral and EEG modalities will allow me to test bilingualism’s effect on functional connectivity, as well as its consequences for functional efficiency, the minimum required neural activation to successfully perform a task. This will enable a detailed, evidence-based account of the protective effects observed in older-aged bilinguals, and how they are built from earlier life stages. By illuminating the relationship between multilingualism and resulting neurocognitive adaptations, BECAME will enable to capitalize on it as a health initiative, with manifold societal implications and the potential to be translated into actionable policies exploiting multilingualism to ameliorate effects of CA.

WHeelchair Activity Monitoring project (WHAM)

Wheelchair users (WCU) are three to five times more inactive than the general population, leading to a high risk of developing preventable secondary conditions. Although physical activity (PA) guidelines have been specifically developed for WCU, we lack systematic approaches to implement them in practice, as well as valid algorithms to monitor PA change in WCU through sensor-based solutions. Accordingly, the overall scientific aim of the WHeelchair Activity Monitoring project (WHAM) is to advance PA research and practice in WCU by developing valid digital markers for monitoring of and providing feedback on PA, paving the way for implementation and intervention. I will accomplish this through combining the complementary research fields of 1) behavioural intervention studies focusing on increasing PA in WCU (core competence University of British Columbia, UBC; outgoing phase) and 2) sensor-based PA monitoring (core competence Norwegian University of Science and Technology, NTNU; returning phase – consolidated by non-academic placement at Maastricht Instruments, which develop research prototypes including PA monitors). WHAM’s scientific aim is achieved through three objectives: 1) Measure the effect of a pragmatic exercise intervention trial on self-reported physical activity levels and cardio-respiratory fitness, 2) Develop valid algorithms for tracking PA markers in WCU, and 3) Co-create a framework that outlines how PA can be conjointly monitored and provided feedback on in WCU. This fellowship will enable me to become established as an internationally recognized researcher in the field of “physical activity and disability”, while bringing together ongoing national disjointed research activities in this field. Altogether, my overall ambition is to contribute to reducing inequalities in daily-life participation among WCU compared to the rest of the population.

Longitudinal Investigation of Visual and Numerical Perception in Preterm and Full-term Infants

The number of preterm births is on the rise -now more than 1 in 10 babies- and being born preterm is associated with having difficulties in two very important and related cognitive skills that we rely on daily: numerical and visual perception. However, a knowledge gap exists on neural and behavioural associations of numerical and visual perception in full-term and preterm infants. PrePER aims to uncover the underlying neural signatures of the cognitive dysfunctions that preterm infants might display in the first year of their lives and the role of parent-baby interaction to predict preterm infants that are at risk of developing these cognitive difficulties in the second year of their lives. The purpose is to establish criteria to identify infants (especially preterm) at-risk of having cognitive difficulties in numerical and visual perception. Shedding light on normal and impaired cognitive functions in infancy is an essential stepping stone that will pave the way for early diagnostic tools and interventions that would correct the cognitive dysfunctions more efficiently while the brain is still developing. The activities in PrePER will lead to original and innovative outcomes that are beneficial for four parties: 1) Scientific communities will be interested in the results as the ambitious research objectives address questions that have not been asked before. 2) Parents of preterm infants, health-care providers, and policy makers will be interested in the results as the overall aim is to establish criteria to identify infants at-risk of having cognitive-developmental difficulties in the first year of their lives. 3) The researcher will be accelerating her career progression as the training objectives meet her specific needs. 4) The supervisor will be enlarging her research interest and network as the research objectives include a topic within the researcher’s expertise.

AQUASERV – RESEARCH INFRASTRUCTURE SERVICES FOR SUSTAINABLE AQUACULTURE, FISHERIES AND THE BLUE ECONOMY

The overarching objectives of AQUASERV are to bring together, enhance, integrate and customise RI capacities (including facilities, instruments and expertise) and through the provision of transnational access (on-site or remote) and/or virtual access, to significantly further scientific advance and promote and facilitate the implementation of European Common Fisheries Policy, the Farm to Fork Strategy, the Sustainable Blue Economy and the European Green Deal. 

AQUASERV will achieve these objectives by offering scientists from academia and business remote and on-site transnational (TA) and virtual (VA) access to an advanced set of European research infrastructures and its nodes related to research and management of marine and freshwater biological resources, food and biotechnology. These include the European Marine Biological Resource Centre ERIC (EMBRC), the Analysis and Experimentation on Ecosystems ERIC, The Aquaculture for Excellence for Aquaculture in Fish (Aquaexcel), and the Infrastructure for Promoting Metrology in Food and Nutrition (METROFOOD), as well as the International Council for Exploration of the Sea, both a service provider and stakeholder. It also includes the Research Infrastructure for Science and Innovation Policy Studies (RISIS) to bring contributions from the social sciences and to bring results nearer to policy makers ensuring societal impact. 

To enhance, integrate and customise RI capacities, collaboration between partners and new pipelines to meet the objectives of the project will be developed during the first 3 years and will make available  to users.  To ensure these capacities will not be lost, a sustainability work package involving stakeholders will address the project legacy.  

To maximize impact, AQUASERV will build a communication network among the partnership and develop a dissemination and outreach programme. Furthermore, an advanced training programme will be developed to capture future users and will be updated during the p

IMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN

EU-OPENSCREEN (EU-OS), the distributed European Research Infrastructure for Chemical Biology and early drug discovery, provides world-class services in high-throughput compound screening and medicinal chemistry to users from academia and industry. As one of the largest open-access initiative globally, EU-OPENSCREEN plays an increasingly important role in facilitating early stage drug discovery in Europe. It recently integrated fragment-based drug discovery and chemoproteomics as two new services, but the increasing complexity of modern drug discovery projects requires an even more comprehensive portfolio and integration of emerging technologies. To ensure that EU-OS continues to offer a comprehensive suite of relevant services and support a growing user community to conduct forefront research, IMPULSE will develop, validate and integrate new services in AI/ML, new chemical modalities, and innovative disease-relevant cell models combined with CRISPR-Cas9/RNAi-based genetic screening. IMPULSE will work towards the implementation of common operational and data standards to increase data reproducibility and FAIRness. Bespoke outreach and training activities will raise awareness among key user groups of its new services and advance operational excellence and reproducibility in pre-clinical drug discovery. New models for pre-competitive drug discovery with industry or charities, and growing ERIC member community will reinforce the sustainability and accessibility of EU-OPENSCREEN.

Strengthening resilience and mental wellbeing through the Support4Resilience toolbox for leaders in elderly care

European elderly care experiences labor shortages, lack of qualified workers and a mismatch between capacity and demands, causing stress, burnout, and reduced mental wellbeing among healthcare workers and informal caregivers. Leaders are crucial in promoting supportive working conditions but lack research-based measures to act upon these challenges.

Support4Resilience (S4R) will develop, implement, and evaluate a research-based Toolbox to support healthcare leaders in improving healthcare workers’ and informal caregivers’ resilience and mental wellbeing in elderly care. S4R will identify resilience and mental wellbeing factors among healthcare workers and informal caregivers; explore their perspectives and needs; develop new theory on the relationship between individual and organizational resilience, and mental wellbeing; and develop recommendations and cost-effective interventions. The Toolbox with tailormade resources for policy and practical use will be available through an open access S4R Resource Bank.

The S4R Toolbox includes three main tools: 1) Mapping and identification, 2) Reflection and education, and 3) Reorganization. Measures are initiated at the organizational level and effects on mental wellbeing and resilience transpire at the frontline of elderly care. The Toolbox covers different situational contexts, types of healthcare providers and health system levels. Elderly care settings in six European countries will implement and evaluate the Toolbox through a process evaluation, effectiveness evaluation, and cost-effectiveness evaluation. 

S4R provides policymakers, decisions-makers and leaders with solutions for taking action to solve specific risks for healthcare workers’ and informal caregivers’ resilience and mental wellbeing. Thus, pertinent to the work programme, S4R will support the development of resilient health systems in European elderly care through improved leadership capabilities, governance structures, and adaptive capacities.

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

The NOVO project will address a fundamental issue in proton radiotherapy (PT) of cancer, namely the lack of real-time dose verification (RDV) that significantly limits the potential of PT due to uncertainties in the precise delivery of the prescribed dose. In the NOVO project, we will develop the first proof-of-concept of an RDV technology adaptable to any PT treatment and bring the concept to TRL 4 by also considering integration into the PT clinical workflow. The RDV technology will be pivotal for enabling the next generation of adaptive PT therapy, i.e., dose-guided real-time adaptive therapy. Real-time measurement of the dose to targeted and non-targeted tissues will be the key to truly empower patient-centered, personalized cancer treatment, important to improve curation and quality-of-life post-treatment. As a high-risk/high-gain project, NOVO aims at a first-of-its-kind RDV technology through the unique synergy between (1) cutting-edge, inexpensive organic scintillator technology that can detect secondary radiation during treatment for non-invasive measurements, (2) novel and fast image reconstruction, artificial intelligence (AI)-accelerated models and AI-enhanced image reconstruction to allow simultaneous detection of multiple radiation species and tissue compositional analysis, (3) tumor-tracking and imaging of tissue radio-sensitivity based on oxygen levels, (4) intelligent automation of decision-making schemes for real-time dose-guided adaptive therapy. The project will essentially open a new era in PT that enables curing more cancer patients and reducing toxicity from treatment. The NOVO consortium covers the entire value chain of RDV development (technology providers, theory and modelling, technology integration and PT clinics) and optimally engages nuclear, medical, and high-energy physicists, chemists, mathematicians, computer scientists, oncologists, biologists, as well as European PT centers. 


Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards of care. The fluorescence of photosensitive molecules (PSs) can precisely guide surgical resection of GBM. Nevertheless, photomedical treatments like photodynamic therapy (PDT) show limited efficacies due to the low penetration of light into tissue. Proton radiotherapy can reach deep-lying disease through therapeutic energy deposition in a spatially confined region called Bragg peak. Current neutron-based therapies, like Boron Neutron Capture Therapy (BNCT), have sufficient penetration depth but lack cancer specificity.
In NuCapCure, we propose to 'hijack' intracellular biosynthetic pathways and use them to produce custom-made drugs that will facilitate two genuinely new cancer treatments: i) "NuCapCure Proton", combining proton radiotherapy, protondynamic therapy through PS proton activation, and proton capture therapy (BPCT) through three produced alpha particles; and ii) "NuCapCure neutron", combining GBM specific BNCT and PS neutron activation as demonstrated in our FET-open project FRINGE.
The main scientific breakthroughs of NuCapCure will be to demonstrate the custom production of novel compounds through native intracellular biosynthesis but also to establish experimental proof-of-principle, both in vitro and in vivo, of the proposed two novel therapies. Our highly interdisciplinary project team comprises world-renowned experts from a unique combination of disciplines: proton and neutron physics, synthetic chemistry, photochemistry, photobiology, radiobiology, medical physics, nuclear reactor and particle accelerator technology and radio-oncology to lay the foundations for novel, targeted and curative therapies against currently fatal cancer indications like GBM.

Despites dental pulp capping materials should meet the certain requirements, the available materials have one or more shortcomings—poor biocompatibility and rheological properties, fail to maintain pulp vitality and to simulate reparative dentine formation and expensive etc. Mineral trioxide aggregate (MTA) is widely used material because of its beneficial properties. However, its composition bismuth oxide, which is suspectable to toxicity, has an impact on rheological properties. This emphasizes the necessity of looking for inexpensive alternatives to materials that meet the specifications. This project's goal and novelty are to investigate the potential processing of the dental pulp capping cement, which is made of strontium silicate (SrSiO3), strontium fluoride (SrF2), piezoelectric material (PZM) and tricalcium silicate (Ca3O5Si) and its rheological properties and hemocompatibility. Because SrSiO3, SrF2, PZM and Ca3O5Si have the promising properties. This project's work packages are split into four categories based on the interdisciplinary approach since it involves the synthesis and characterization of PZM, the processing and characterization of cement, the identification of rheological parameters utilizing ISO standardizations, and hemocompatibility, and acquiring new transferrable skills. Additionally, the interactions among the selected compounds will be determined. The scientific impact of this project is comprehending the physical properties and the immune system's response to evaluate the cement's suitability as a replacement for existing materials, as well as resulting in further uses in dentistry and medicine. The societal impact is providing millions of patients in Europe with predictable and outstanding treatment outcomes each year to maintain pulp vitality and health. Eventually, it will ease the financial load on millions of patients who need dental care, will be avoiding inflated medical expenses and misuse of the patent (economic impact).

SrSiO3-based Dental Pulp Capping Cement

PATHWAY: Verktøy for å beskrive og kommunisere pasientforløp

Midlene fra HELSEVEL-Gode og effektive helse-, omsorgs- og velferdstjenester fordelt på år

Midlene fra HELSEVEL-Gode og effektive helse-, omsorgs- og velferdstjenester fordelt på fylker

Midlene fra HELSEVEL-Gode og effektive helse-, omsorgs- og velferdstjenester fordelt på fagområde

Seniorforsker

Pasientforløp har blitt et viktig begrep i helsesammenheng, og brukes av fagpersoner med forskjellig bakgrunn, f.eks. klinikere, koordinatorer og teknologer.  Mangelen på et samlende rammeverk for pasientforløp har resultert i en mengde ikke-standardiserte beskrivelser og formater, og begrepsavklaringer forekommer sjelden. Et pasientforløp er definert som en kronologisk beskrivelse av pasientens møte med helsevesenet. Men i praksis brukes pasientforløp mest av sykehus for å sikre at pasienter får helsehjelp innenfor gitte tidsfrister. Pasientforløp omfatter som regel kun én institusjon, og har sjelden pasientens helhetsperspektiv i fokus.
Visjonen i prosjektet Pathway er å utvikle et teoretisk fundament og et visuelt modelleringsspråk for å beskrive, forbedre og kommunisere pasientforløp. Pathway er forankret i pasientens perspektiv. Vi vil derfor involvere pasienter, pårørende og pasientorganisasjoner i forskningsaktivitetene. Prosjektet tar utgangspunkt i to sykdomsgrupper: pasienter med multippel sklerose (MS), som er en kronisk, livslang nevrologisk sykdom, og pasienter med nyrekreft. Dette er for å favne ulike typer pasientforløp, men også for å se på forskjeller innad i gruppene. Målet er å etablere verktøy og metoder som kan beskrive alle typer pasientforløp, og som bidrar til å skape gode og helhetlige pasientopplevelser. 

I prosjektet starter vi med å undersøke pasientenes opplevelse av sitt forløp, og hvilke faktorer de opplever at hemmer eller fremmer god sammenheng i forløpet. I tillegg kartlegger vi hvordan deres konkrete forløp ser ut ved hjelp av metoder som intervjuer og loggføring av kontakter med helsetjenestene. Vi gjennomfører nå en detaljert kartlegging av individuelle pasientforløp for MS-pasienter og kreftpasienter. Dette materialet vil bli sammenholdt med helseaktørenes planlagte/standardiserte forløp. I juni 2022 gjennomførte vi også en rekke workshops og intervjuer med kreftpasienter og deres pårørende. Her var temaet kommunikasjon og informasjonsflyt gjennom pasientforløpet. Ved hjelp av metoden Critical incident technique identifiserte vi kritiske faktorer for gode pasientforløp. 

Prosjektets postdoc og PhD-student gjennomfører nå en systematisk litteraturgjennomgang og en survey av pasientforløp; hvordan de beskrives, modelleres og kommuniseres både mellom helsepersonell og direkte til pasientene. Flere intervjustudier med helsepersonell er også i gang, med fokus på håndtering av pasientforløp. 

Resultatet av prosjektet er en verktøykasse for presise, visuelle modeller for pasientforløp som vil gjøre det lettere å oppnå en felles forståelse og kommunisere på tvers av ulike profesjoner. Verktøyene skal også utvikles med tanke på å kommunisere direkte med pasienten.

Pathway ledes av SINTEF Digital, og prosjektpartnere er Universitetet i Oslo og Universitetet i Aalto, Finland. Vi vil gjøre studier i samarbeid med universitetssykehuset i Oslo og Helsinki og sammenligne resultater mellom sykdomsgrupper og land. Prosjektverktøyene vil bli offentlig tilgjengelig for alle, og promotert gjennom offentlige seminarer.

Patient pathways are in-house tools for hospital staff. However, the lack of a unifying framework for pathways has resulted in a plethora of non-standard descriptions, definitions, and evidence. PATHWAY's vision is to establish the knowledge needed to manage and communicate patient pathways using precise models and methods. The overall project objective is to develop the PATHWAY framework consisting of a theoretical fundament, a visual multi-layered modelling language, methods, and tools to support description, design, and management of patient pathways.
While patients often find the medical treatment excellent, research has shown that they experience poor coordination and information exchange among the healthcare actors. This highlights the need for new approaches to manage and coordinate patient pathways in the healthcare system.
Based on a strong involvement of users, we will investigate patient pathways from the healthcare organizations' points of view but also through longitudinal studies of patient journeys on an individual level. User needs will inform the development of the modelling language.
The modelling language will cover several process layers like the patient's direct contact points and actions, clinical and logistic workflows. 
The modelling language will be evaluated with several target groups for various purposes within and across disease groups, health organizations and health regions in Norway and Finland. We we will explore how the framework can support direct communication towards patients for increased predictability and patient empowerment.
The outcome of the project is a toolkit for precise, visual representations of patient pathways that will ease communication and provide a common understanding among health professionals. A handbook with guidelines and best practices for managing and communicating pathways will also be provided.
The research partners are SINTEF Digital, University of Oslo, and Aalto University, Finland.

PATHWAY: A toolkit for managing and communicating patient pathways

Naturhistorisk museum (NHM) ved Universitetet i Oslo (UiO) arrangerte det 8th International Symposium on Granitic Pegmatites PEG2017 i Kristiansand 13.-15. januar 2017 og medfølgende geologiske ekskursjoner til Tysfjord-Hamarøy 9.-13. juni og Setesdalen-Langesundsfjorden 16.-19. juni 2017 (http://www.nhm.uio.no/forskning/aktuelt/arrangementer/konferanser-seminarer/peg2017/).
Serien av International Symposium on Granitic Pegmatites (PEG) ble startet i 2003 og avholdes annethvert år. Konferansen tiltrekker seg forskere fra hele verden som jobber innenfor ulike fagmiljøer økonomisk geologi, mineralogi, petrologi, gemologi og mineralprosessering. Konferansedeltakerne har et felles forskningsfelt: Pegmatitter. Pegmatitter er definert som grovkornede bergarter av magmatisk opprinnelse (smeltebergart) med krystallstørrelse > 2 cm. Pegmatitter er i dag svært viktige økonomiske kilder for sjeldne grunnstoffer med høyteknologiske applikasjoner (Li, Ce, Rb, Nb, Ta, Be, og REE) og vanlige industrimineraler som for eksempel feltspat, kvarts, og glimmer. Niob, beryllium og REE er rangert som kritiske materialer av EU-kommisjonen, noe som betyr at disse råmaterialer er avgjørende for både Europas og verdens økonomi, og i stadig økende grad en forutsetning for å opprettholde og forbedre vår levestandard. Behovet for en sikker og langsiktig tilgang til slike ressurser er en økende bekymring i EU og over hele verden, og er et satsningsområde gjennom forskning og geologisk kartlegging. Litium brukes i litiumbatterier, kvarts er en hovedkilde for produksjon av solcellepaneler, REE brukes i neodymmagneter i vindturbiner. Disse er bare noen få eksempler på moderne applikasjoner, men alle eksemplene illustrerer den høye betydningen av pegmatittforskning i forhold til produksjon av alternativ og fornybar energi. I tillegg er pegmatitter den viktigste kilden til edelstener.
Derfor har forskning om mangfold, fordeling, og dannelse av pegmatitter en avgjørende vitenskapelig og økonomisk betydning. Dannelsen av pegmatitter er lite forstått og er dermed den mest kontroversielle og omdiskuterte bergarten. I nyere tid er pegmatitter i økende grad et stort forskningstema innen petrologi og mineralogi. På grunn av dette og den økende oppmerksomheten rundt PEG-konferansen ble NHM tilbudt å organisere PEG2017 med full støtte i forskningsmiljøet. 
80 forskere fra 23 land deltok på PEG2017 konferansen i Kristiansand og medfølgende ekskursjoner til Tysfjord-Hamarøy og Setesdalen-Langesundsfjorden. Tre «keynote» forelesninger, 26 faglige foredrag, og 25 plakater ble presentert under de to forelesningsdagene på Agder Universitet i Kristiansand (http://www.nhm.uio.no/forskning/aktuelt/arrangementer/konferanser-seminarer/peg2017/program/peg2017-scientific-programme.pdf). PEG2017 ble offisielt åpnet ved en icebreaker sammenkomst på Agder Naturmuseum og Botanisk hage, museumsturer ble tilbudt under konferansen, og avsluttende konferansemiddag ble avholdt på Klubben Selskapslokaler Kristiansand med kulturelle innslag. Ekskursjonen til Tysfjord-Hamarøy i forkant av konferansen besto av 25 deltakere fra 7 forskjellige land. Denne ekskursjonen besøkte historiske pegmatittgruver på Stetind, Hundholmen, aktive gruver på Jennyhaugen, Drag og Hakonhåls, og et besøk til kvartsprosesseringsanlegget ved Drag drevet av The Quartz Corp. Under Setesdal-Langesundsfjord ekskursjonen i etterkant av konferansen ble det besøkt historiske og aktive gruver på Steli, Solås, Hovåsen, Li, Landsverk og Tveidalen med 44 deltakere. Totalt ble rundt 200 kg steinprøver samlet inn for framtidige samarbeidsprosjekter og for å utvide NHM sine mineralsamlinger. Ekskursjonene fikk også oppmerksomhet i lokale aviser (for eksempel http://redir.opoint.com/?key=IKGUlYFZ3ZUS1J5O2B0F og http://www.setesdolen.no/ 29. juni 2017).
Sammendrag av PEG2017 konferansen og tilhørende ekskursjoner er offentliggjort via NHM Mineralblogg http://www.nhm.uio.no/fakta/geologi/nyheter/mineralbloggen/. Sammendrag av alle faglige presentasjoner og ekskursjonsguider for PEG2017 er fritt tilgjengelige på Norsk Geologisk Forening sin nettside http://www.geologi.no/konferanser/andre-konferanser/item/909-peg2017. 
Kort oppsumert var PEG2017-konferansen en stor suksess når det gjelder å plassere NHM sin mineralogigruppe i forskningsfronten av internasjonal pegmatittforskning, og styrke internasjonale nettverk mellom pågående og fremtidige forskingsprosjekter med den hensikt å sikre fremtidig mineralforsyning og utvikle nye materialløsninger for produksjon av alternativ og fornybar energi.

The Natural History Museum (NHM) of the University of Oslo is organizing the 8th International Symposium on Granitic Pegmatites PEG2017 in Kristiansand June 13 to 15, 2017, and likes to apply for financial support for conference organization in the amount of 248 000 NOK. The conference will gather c. 150 international scientists working in the geoscience fields of economic geology, mineralogy, petrology, gemology, and mineral processing. The total cost of the conference including field course excursions to the Tysfjord, Setesdalen and Langesund areas is 1 492 000 NOK. Several industrial partners including The Quartz Corp AS, Sibelco Nordic AS, Elkem Solar, and Larvik Granite will support the conference financially and logistically.
The series of International Symposia on Granitic Pegmatites (PEG) started in 2003, is biennial and attracts 100 to 200 scientists from all over the world having one study subject in common: Pegmatites. Pegmatites are economically important sources of lithium, cesium, rubidium, niobium, tantalum, beryllium, rare earth elements (REE), feldspar, quartz and mica. Niobium, beryllium and REE are classified as critical materials by the European Commission meaning these are raw materials that are crucial to Europes and the Worlds economy. Lithium is used in lithium batteries, quartz in solar photovoltaic panels and REE for neodymium magnets in wind turbines. These examples illustrate the high importance of pegmatite research in relation to the production of alternative and renewable energy. Thus, research on the diversity and genesis of pegmatites has a crucial scientific and economic importance and impact. Because of the increasing attention paid to the PEG conferences, the NHM was offered organizing PEG2017. The conference is important both in relevance of ongoing research at the NHM, and as a funnel for current high-end research within the pegmatite science and will place the NHM and UiO in the lead of the fore-front research.

0 projects

FRINATEK-Fri prosj.st. mat.,naturv.,tek

8th International Symposium on Granitic Pegmatites PEG2017

Awarded: NOK 73,999

Project Period: 2017-2018

Location: Oslo